• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Analog Devices Earnings, Revenue Beat in Q2 By Investing.com

May 18, 2022 admin 0

© Reuters. Analog Devices Earnings, Revenue Beat in Q2 Investing.com – Analog Devices (NASDAQ:) reported on Wednesday second quarter that beat analysts’ forecasts and revenue that topped expectations. Analog Devices announced earnings per share of […]

Stock News

Goldman Sachs Launches Coverage on 8 Payments Stocks, Adds Visa to Its Conviction Buy List By Investing.com

May 18, 2022 admin 0

© Reuters. Goldman Sachs Launches Coverage on 8 Payments Stocks, Adds Visa (V) to Its Conviction Buy List Goldman Sachs (NYSE:) analyst Will Nance launches research coverage on eight payment stocks with three stocks getting […]

Stock News

Target profit halves on rising costs, warns of bigger margin hit By Reuters

May 18, 2022 admin 0

© Reuters. FILE PHOTO: Signage is seen at a Target store in Manhattan, New York City, U.S., November 22, 2021. REUTERS/Andrew Kelly (Reuters) – Target Corp (NYSE:)’s first-quarter profit halved and it warned of a […]

Posts navigation

« 1 … 21,150 21,151 21,152 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • BDCs: Fidus Investment Looks More Attractive Than Goldman Sachs BDC
    January 18, 2023 0
  • NuCana Stock: A Major Patent Litigation Win Against Gilead
    July 13, 2022 0
  • Synopsys Stock: A Growth Story Hard To Ignore (NASDAQ:SNPS)
    July 1, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.